NEW YORK — The guessing game over higher interest rates is making for a jerky stock market.A day after their biggest gain in six weeks, stock indexes mostly fell on Tuesday as oil continued to slide and investors fretted over when the Federal Reserve will raise a key borrowing rate. The Fed kicked off a two-day meeting on Tuesday to […]
Traders work on the floor of the New York Stock Exchange on March 16, 2015.Many Americans believe that the economic recovery has only recently picked up steam. But one group that is widely seen as benefiting in recent years are investors in the stock market. This is a point that former Sen. James Webb, D-Va. — a potential longshot candidate […]
The biotechnology story is one that continues to highlight evolving growth opportunities in the medical field. Whether you are a believer in the high valuations or not, these stocks have consistently posted double digit gains for more than half a decade and enthralled investors with their resiliency. That makes biotechnology companies worthy of consideration for those that are seeking high […]
Billionaire Seth Klarman is a notorious investor who despite his uncoventional approaches always managed to achieve high returns. He founded Baupost Group in 1982 with around $30 million and since then the hedge fund grew to one of the biggest in the world and currently manages over $28 billion in assets. Mr. Klarman is very secretive about his strategies, which […]
In a recent report, analysts at Maxim Group discussed the biotechnology sector and gave their outlook for five names in the space. Here’s a rundown of what they had to say.Athersys, Inc. (NASDAQ: ATHX)Analysts believe that Athersys may have found a “sweet spot” for stroke treatment timing, as data from a phase II trial of MultiStem treatment one to two […]
Gilead Sciences’ (NASDAQ: GILD) blockbuster launches of the hepatitis C drugs Sovaldi and Harvoni resulted in its revenue jumping 122% in 2014, but with Gilead Sciences facing tough comparisons this year, these three big-cap biotech stocks may be in better positions to see their shares climb in 2015http://www.fool.com/investing/general/2015/03/01/3-big-cap-biotechs-that-could-trounce-gilead-scien.aspx
Source:
3 Big Cap Biotechs That Could Trounce Gilead Sciences This Year
See which stocks […]
The bull market turned six-years-old this week, which is pretty amazing. It’s been quite a ride. In that time, the Dow Jones Industrial Average has charged ahead more than 150%, the S&P 500 180% and Nasdaq 250%. One group that has been at the forefront of this bull market is biotech stocks.Source: FlickrIn fact, the past five years have been […]
The 4 Stocks That Dominated the Market ThursdayBy Paul Ausick March 12, 2015 4:01 pm EDTPrintEmail March 12, 2015: Markets opened higher on Thursday even though the report on U.S. retail sales was disappointing. Foreign markets contributed an interest rate cut (Korea), better-than-expected employment data (Australia), and rumors of more stimulus (China). Gold ticked up today, and crude oil dropped […]
Stock Trading Alert: Uncertainty Following Recent Sell-Off – Will Downtrend Continue?By: Paul Rejczak | Thu, Mar 12, 2015SharePrintEmailStock Trading Alert originally published on March 12, 2015, 7:53 AM:Briefly: In our opinion, speculative short positions are favored (with stop-loss at 2,090 and profit target at 1,980, S&P 500 index)Our intraday outlook is bearish, and our short-term outlook is bearish:Intraday outlook (next […]
Submitted by Michael Snyder via The Economic Collapse blog,Is this the end of the last great run for the U.S. stock market? Are we witnessing classic “peaking behavior” that is similar to what occurred just before other major stock market crashes? Throughout 2014 and for the early stages of 2015, stocks have been on quite a tear. Even though the […]
